GlassScriptPhysician profile
Amy B Hessler
NPI 1265559389
$33,193.08
in general payments reported to CMS, 2019-2025
45 companies · $22K in 2025
The $22K reported for 2025 was more than what 93% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.00 · 2023: $1,625 · 2024: $9,528 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $7,534 · Consulting Fee: $6,500 · Honoraria: $6,000 · Education: $66.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,000.00 |
| Food and Beverage | $7,534.21 |
| Consulting Fee | $6,500.37 |
| Honoraria | $6,000.00 |
| Education | $66.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15,085.37 | 2023-2025 | |
| Lundbeck LLC | $11,958.72 | 2023-2025 | Vyepti, Rexulti |
| Pfizer INC. | $1,730.39 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $616.32 | 2023-2025 | |
| Lilly USA, LLC | $426.81 | 2023-2025 | Kisunla, Amyvid, Emgality |
| Ucb, INC. | $225.14 | 2023-2025 | Nayzilam, Briviact, Rystiggo |
| Otsuka America Pharmaceutical, INC. | $219.63 | 2023-2025 | Rexulti, Nuedexta |
| Teva Pharmaceuticals USA, INC. | $214.67 | 2023-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Eisai INC. | $213.33 | 2023-2024 | |
| Kyowa Kirin, INC. | $210.54 | 2023-2025 | Nourianz |
| Jazz Pharmaceuticals INC. | $198.91 | 2023-2025 | |
| Axsome Therapeutics, INC. | $186.99 | 2023-2025 | Auvelity, Sunosi, Symbravo |
| Takeda Pharmaceuticals U.S.A., INC. | $154.77 | 2024-2025 | Hyqvia |
| Sk Life Science, INC. | $133.08 | 2024 | Xcopri |
| Mdd US Operations, LLC | $127.48 | 2024-2025 | Gocovri |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $124.41 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $113.02 | 2023-2025 | Valtoco |
| Amgen INC. | $112.40 | 2023-2025 | Aimovig, Uplizna |
| Microtransponder, INC. | $106.54 | 2025 | |
| Mallinckrodt Enterprises LLC | $92.00 | 2019 | |
| Argenx US, INC. | $81.59 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Genentech USA, INC. | $76.24 | 2024-2025 | Ocrevus Zunovo, Ocrevus |
| Biogen, INC. | $73.21 | 2023-2025 | Skyclarys, Skyclarys |
| Neurocrine Biosciences, INC. | $65.26 | 2023-2025 | Ongentys, Ingrezza |
| Emd Serono, INC. | $64.25 | 2023-2025 | Mavenclad |
| Vanda Pharmaceuticals INC. | $62.51 | 2024-2025 | Ponvory |
| Alexion Pharmaceuticals, INC. | $59.75 | 2023-2024 | Ultomiris, Soliris |
| Impel Pharmaceuticals LLC | $44.52 | 2025 | Trudhesa |
| Csl Behring | $40.80 | 2023-2025 | Hizentra |
| Janssen Pharmaceuticals, INC | $40.52 | 2024-2025 | Spravato |
| Grifols USA, LLC | $35.54 | 2024 | Gamunex-C |
| Globus Medical, INC. | $34.78 | 2025 | Senza |
| C2n Diagnostics, LLC | $28.95 | 2025 | Precivityad2 |
| Janssen Biotech, INC. | $26.96 | 2025 | |
| Amneal Pharmaceuticals LLC | $22.42 | 2024 | Ongentys |
| Tg Therapeutics, INC. | $21.94 | 2025 | |
| Averitas Pharma INC. | $21.49 | 2023 | Qutenza |
| Mallinckrodt Hospital Products INC. | $20.30 | 2023 | Acthar |
| Octapharma USA, INC. | $19.28 | 2024 | Panzyga |
| Inspire Medical Systems, INC. | $19.21 | 2025 | Inspire |
| Azurity Pharmaceuticals, INC. | $18.43 | 2024 | Horizant |
| Tanabe Pharma America, INC. | $17.80 | 2024 | |
| Mylan Specialty L.P. | $16.30 | 2023 | Glatiramer Acetate |
| Insightec,INC | $15.30 | 2025 | Exablate |
| Impel Pharmaceuticals INC. | $15.21 | 2023 | Trudhesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Hessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.